AAVS Campaigns are areas of special interest that align with the core values of our organization and its members. Working towards milestones and resolutions in these areas is what drives our mission, and focuses our energy.
Class B Dealers
Class B Dealers acquire animals that have not been purpose-bred or raised on the dealers’ property from “rand sources” such as auction sales, other USDA–licensed dealers, pounds and shelters, and from private persons who have raised and bred the animal on their own premises; and sell them to research, testing, and education facilities. AAVS would like to see all Class B Dealers shut down.
AAVS is working to end the sale or release of dogs and/or cats from pounds or shelters to research, testing, or educational facilities.
Birds, Mice, and Rats
Birds, rats, and mice represent roughly 95 percent of animals used in research, and they currently have no legal protection. AAVS is working toward modifying the Animal Welfare Act to grant them the same protection as other species like dogs, cats, and rabbits.
Genetic engineering is the manipulation of the genetic code (the DNA, or genes) of a living organism. Not only does it represent one of the greatest threats to animals used in research, but it also has the potential to fundamentally change how humans view and use animals – for the worse. AAVS opposes genetic engineering, and works to prevent and discontinue this practice.
AAVS is working to end animal cloning. Cloning is the practice of artificially creating organisms that have the same DNA structure. Cloning is used to create copies of ‘valuable’ animals, and to recreate the results of genetic engineering. Serious health problems associated with cloned animals lead to numerous concerns over animal welfare, the safety of food products from cloned animals, and the ethics of cloning — concerns which need to addressed before food from cloned animals or their offspring are allowed on the market.
Private companies, universities, and individual ‘bioentrepreneurs’ have been granted over 660 patents on animals such as chimpanzees, monkeys, mice, rabbits, dogs, cats, and pigs who have been ‘altered’ in some way, creating an incentive to profit from harming animals. It is our position at AAVS, however, that it is an unethical and inappropriate use of the patent system to issue patents for sentient beings.